Resultados de la búsqueda 321-330 of 11177 for praluent side afects

  1. Oncología (médica) - Ensayos clínicos

    We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...

  2. Oncología (médica) - Ensayos clínicos

    We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the effect of capecitabine and ... side effects of this drug combination. Everyone in this study will receive ...

  4. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination ... negative [HER2, estrogen and progesterone receptor (ER and PR) all negative] ...

  6. Oncología (médica) - Ensayos clínicos

    We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...

  7. Hematología - Ensayos clínicos

    This phase I trial studies the best dose and side effects of recombinant ... adverse effects of cancer therapy (single or multiple) and stem cell transplant.

  8. Hematología - Ensayos clínicos

    This phase I trial studies the best dose and side effects of recombinant ... adverse effects of cancer therapy (single or multiple) and stem cell transplant.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...

  10. Oncología (médica) - Ensayos clínicos

    We also want to learn about the side effects of this combination. All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib ...